Home  /  Resource Library  /  Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US

Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US

Study examined patient preferences for bispecific antibodies in treatment of DLBCL.